ESC Professional Premium Access

Real-world data from the use of ranolazine in patients with stable angina pectoris: the RANGER study

Congress Session

About the speaker

Doctor Panagiotis STAFYLAS

HealThink, Thessaloniki (Greece)
1 follower

6 more presentations in this session

Effect of exercise-based cardiac rehabilitation on the ischemic threshold in patients with high-risk ischemic heart disease

Speaker: Doctor J. Lara Vargas (Ciudad de Mexico, MX)

Thumbnail

Impact of different antiplatelet therapy cessation modes on outcomes in patients treated with ticagrelor with or without aspirin after PCI: the twilight-antiplatelet cessation study

Speaker: Doctor A. Spirito (New York, US)

Thumbnail

Long-term effects of phosphodiesterase-5 inhibitors on cardiovascular outcomes and death: a systematic review and meta-analysis of cohort studies

Speaker: Mr S. Soulaidopoulos (Athens, GR)

Thumbnail

Low dose rivaroxaban therapy in aspirin allergic patients undergoing percutaneous coronary intervention

Speaker: Doctor S. Manjooran (London, GB)

Thumbnail

Lipoprotein(a), cardiovascular events, and benefit of P2Y12 inhibition: insights from the PEGASUS-TIMI 54 trial

Speaker: Doctor S. Patel (Boston, US)

Thumbnail

Access the full session

Coronary artery disease - Pharmacotherapy 3

Speakers: Doctor P. STAFYLAS, Doctor J. Lara Vargas, Doctor A. Spirito, Mr S. Soulaidopoulos, Doctor S. Manjooran...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk